Leukemia - Table of Contents alert Volume 26 Issue 8

TABLE OF CONTENTS Volume 26, Issue 8 (August 2012) In this issue How to Manage… Original Articles Letters to the Editor Also new AOP Advertisement BD Reagents for Blood Cell Disorders Part of the building blocks to support patient care for blood cell disorders, BD Biosciences reagents provide a full spectrum of color choices, allowing you to analyze multiple parameters simultaneously and access a whole new world of information and insight. Welcome to a more colorful world SM. bdbiosciences.com/go/color Sign up for e-alerts Recommend to yourlibrary Web feed Subscribe Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical, academic and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   How to Manage… Top How to manage acute promyelocytic leukemia J-Q Mi, J-M Li, Z-X Shen, S-J Chen and Z Chen Leukemia 2012 26: 1743-1751; advance online publication, March 16, 2012; 10.1038/leu.2012.57 Abstract | Full Text Original Articles Top MOLECULAR TARGETS FOR THERAPY Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells Y Yu, L Yang, M Zhao, S Zhu, R Kang, P Vernon, D Tang and L Cao Leukemia 2012 26: 1752-1760; advance online publication, March 7, 2012; 10.1038/leu.2012.65 Abstract | Full Text Optimal induction of myeloma cell death requires dual blockade of phosphoinositide 3-kinase and mTOR signalling and is determined by translocation subtype C Stengel, C W Cheung, J Quinn, K Yong and A Khwaja Leukemia 2012 26: 1761-1770; advance online publication, March 14, 2012; 10.1038/leu.2012.69 Abstract | Full Text THERAPY Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent M Benezra, E Phillips, D Tilki, B-S Ding, J Butler, K Dobrenkov, B Siim, D Chaplin, S Rafii, S Rabbany and M S Bradbury Leukemia 2012 26: 1771-1778; advance online publication, February 20, 2012; 10.1038/leu.2012.48 Abstract | Full Text Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients A Rambaldi, A Bacigalupo, R Fanin, F Ciceri, F Bonifazi, M Falda, G Lambertenghi-Deliliers, F Benedetti, B Bruno, P Corradini, P E Alessandrino, P Iacopino, W Arcese, R Scimè, R Raimondi, S Sica, L Castagna, T Lamparelli, R Oneto, L Lombardini, S Pollichieni, A Algarotti, A Carobbio, N Sacchi and A Bosi on behalf of Gruppo Italiano Trapianto di Midollo Osseo, GITMO Leukemia 2012 26: 1779-1785; advance online publication, March 1, 2012; 10.1038/leu.2012.55 Abstract | Full Text ACUTE LEUKEMIAS Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin R Parameswaran, M Yu, M-A Lyu, M Lim, M G Rosenblum, J Groffen and N Heisterkamp Leukemia 2012 26: 1786-1796; advance online publication, February 29, 2012; 10.1038/leu.2012.54 Abstract | Full Text CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia A Inthal, P Zeitlhofer, M Zeginigg, M Morak, R Grausenburger, E Fronkova, B Fahrner, G Mann, O A Haas and R Panzer-Grümayer Leukemia 2012 26: 1797-1803; advance online publication, March 5, 2012; 10.1038/leu.2012.60 Abstract | Full Text MYELODYSPLASIAS 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity N Curik, P Burda, K Vargova, V Pospisil, M Belickova, P Vlckova, F Savvulidi, E Necas, H Hajkova, C Haskovec, J Cermak, M Krivjanska, M Trneny, P Laslo, A Jonasova and T Stopka Leukemia 2012 26: 1804-1811; advance online publication, February 20, 2012; 10.1038/leu.2012.47 Abstract | Full Text CHRONIC LYMPHOCYTIC LEUKEMIA Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia M Sivina, E Hartmann, E Vasyutina, J M Boucas, A Breuer, M J Keating, W G Wierda, A Rosenwald, M Herling and J A Burger Leukemia 2012 26: 1812-1820; advance online publication, March 5, 2012; 10.1038/leu.2012.63 Abstract | Full Text The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation T Lion, F Watzinger, S Preuner, H Kreyenberg, M Tilanus, R de Weger, J van Loon, L de Vries, H Cavé, C Acquaviva, M Lawler, M Crampe, A Serra, B Saglio, F Colnaghi, A Biondi, J J M van Dongen, M van der Burg, M Gonzalez, M Alcoceba, G Barbany, M Hermanson, E Roosnek, C Steward, J Harvey, F Frommlet and P Bader on behalf of the EuroChimerism Consortium (EU-Project number: QLG1-CT-2002-01485) Leukemia 2012 26: 1821-1828; advance online publication, March 7, 2012; 10.1038/leu.2012.66 Abstract | Full Text ONCOGENES, FUSION GENES AND TUMOR SUPPRESSOR GENES Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding A Ptasinska, S A Assi, D Mannari, S R James, D Williamson, J Dunne, M Hoogenkamp, M Wu, M Care, H McNeill, P Cauchy, M Cullen, R M Tooze, D G Tenen, B D Young, P N Cockerill, D R Westhead, O Heidenreich and C Bonifer Leukemia 2012 26: 1829-1841; advance online publication, February 20, 2012; 10.1038/leu.2012.49 Abstract | Full Text Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia A Zebisch, A Wölfler, I Fried, O Wolf, K Lind, C Bodner, M Haller, A Drasche, D Pirkebner, D Matallanas, O Rath, K Blyth, R Delwel, E Taskesen, F Quehenberger, W Kolch, J Troppmair and H Sill Leukemia 2012 26: 1842-1849; advance online publication, March 5, 2012; 10.1038/leu.2012.61 Abstract | Full Text DIFFERENTIATION p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells M Gianni, M Peviani, N Bruck, A Rambaldi, G Borleri, M Terao, M Kurosaki, G Paroni, C Rochette-Egly and E Garattini Leukemia 2012 26: 1850-1861; advance online publication, February 22, 2012; 10.1038/leu.2012.50 Abstract | Full Text MYELOMA Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients B Paiva, N-C Gutiérrez, X Chen, M-B Vídriales, M-Á Montalbán, L Rosiñol, A Oriol, J Martínez-López, M-V Mateos, L López-Corral, E Díaz-Rodríguez, J-J Pérez, E Fernández-Redondo, F de Arriba, L Palomera, E Bengoechea, M-J Terol, R de Paz, A Martin, J Hernández, A Orfao, J-J Lahuerta, J Bladé, A Pandiella and J-F San Miguel on behalf of the GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study groups Leukemia 2012 26: 1862-1869; advance online publication, February 15, 2012; 10.1038/leu.2012.42 Abstract | Full Text Curative one-shot systemic virotherapy in murine myeloma S Naik, R Nace, M J Federspiel, G N Barber, K-W Peng and S J Russell Leukemia 2012 26: 1870-1878; advance online publication, March 19, 2012; 10.1038/leu.2012.70 Abstract | Full Text Letters to the Editor Top Novel splicing-factor mutations in juvenile myelomonocytic leukemia J Takita, K Yoshida, M Sanada, R Nishimura, J Okubo, A Motomura, M Hiwatari, K Oki, T Igarashi, Y Hayashi and S Ogawa Leukemia 2012 26: 1879-1881; advance online publication, February 20, 2012; 10.1038/leu.2012.45 Full Text Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia B G Mar, L Bullinger, E Basu, K Schlis, L B Silverman, K Döhner and S A Armstrong Leukemia 2012 26: 1881-1883; advance online publication, March 1, 2012; 10.1038/leu.2012.56 Full Text Evaluating surface erythropoietin receptor in multiple myeloma C P Miller, K Rattray, Y Zhang, B L Wood, N Burwick, S Chien, W I Bensinger, C A Blau and P S Becker Leukemia 2012 26: 1883-1886; advance online publication, March 1, 2012; 10.1038/leu.2012.58 Full Text A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation E Clave, D Lisini, C Douay, G Giorgiani, M Busson, M Zecca, D Charron, M E Bernardo, A Toubert and F Locatelli Leukemia 2012 26: 1886-1888; advance online publication, March 5, 2012; 10.1038/leu.2012.59 Full Text Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction A Naji, C Menier, G Maki, E D Carosella and N Rouas-Freiss Leukemia 2012 26: 1889-1892; advance online publication, March 5, 2012; 10.1038/leu.2012.62 Full Text SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants Z-X Cao, J-J Liu, R-L Zheng, J Yang, L Zhong, Y Xu, L-J Wang, C-H Zhang, B-L Wang, S Ma, Z-R Wang, H-Z Xie, Y-Q Wei and S-Y Yang Leukemia 2012 26: 1892-1895; advance online publication, March 9, 2012; 10.1038/leu.2012.67 Full Text Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease C Royo, A Navarro, G Clot, I Salaverria, E Giné, P Jares, D Colomer, A Wiestner, W H Wilson, M C Vegliante, V Fernandez, E M Hartmann, N Trim, W N Erber, S H Swerdlow, W Klapper, M J S Dyer, M Vargas-Pabón, G Ott, A Rosenwald, R Siebert, A López-Guillermo, E Campo and S Beà Leukemia 2012 26: 1895-1898; advance online publication, March 19, 2012; 10.1038/leu.2012.72 Full Text Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical, academic and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.